List of insiders holdings for Quince Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | LAMOND PIERRE Lamond Christine 10% Owner |
2019-09-30 08:43:53 | 2,886,530 0 |
2,886,530 | Form 13G |
| 2 | Thye Dirk CEO AND CHIEF MEDICAL OFFICER |
2025-02-11 17:44:38 | 1,200,000 0 |
1,200,000 | Form 4 |
| 3 | PFIZER INC Pfizer Strategic Investment Holdings LLC Pfizer Ventures (US) LLC 10% Owner |
2022-02-11 18:06:57 | 600,000 0 |
600,000 | Form 13G |
| 4 | Low Philip S Director |
2022-05-23 20:17:43 | 477,367 63,974 |
541,341 | Form 4 |
| 5 | Hannah Brendan CBO, COO and CCO |
2025-02-11 17:41:41 | 450,000 0 |
450,000 | Form 4 |
| 6 | Lynch Casey Chief Executive Officer |
2022-01-05 17:26:18 | 440,000 0 |
440,000 | Form 4 |
| 7 | Ryan Charles S. PRESIDENT |
2025-02-11 17:43:17 | 300,000 0 |
300,000 | Form 4 |
| 8 | Janhofer Guenter Chief Scientific Officer |
2023-10-24 19:42:07 | 300,000 0 |
300,000 | Form 4 |
| 9 | LOWE CHRISTOPHER P. Interim CEO, COO & CFO |
2022-03-04 17:55:40 | 265,000 0 |
265,000 | Form 4 |
| 10 | Smith Karen L. Chief Medical Officer |
2023-02-02 18:35:56 | 225,000 0 |
225,000 | Form 4 |
| 11 | Holsinger Leslie EVP, Preclinical Development |
2022-06-08 16:10:58 | 148,080 0 |
148,080 | Form 4 |
| 12 | Detke Michael J. Chief Medical Officer |
2022-03-04 17:39:59 | 140,000 0 |
140,000 | Form 4 |
| 13 | Dominy Stephen S. Chief Scientific Officer |
2022-01-05 16:53:10 | 125,000 0 |
125,000 | Form 4 |
| 14 | McDowell Caryn Gordon Chief Legal & Adm. Officer |
2022-06-08 16:09:19 | 122,500 0 |
122,500 | Form 4 |
| 15 | Gafric Kristen SVP, Legal & Administration |
2020-02-10 18:13:59 | 100,000 0 |
100,000 | Form 4 |
| 16 | Takeda Ventures Inc. TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals International AG Takeda Pharmaceuticals U.S.A. Inc. 10% Owner |
2021-01-28 17:57:44 | 87,258 0 |
87,258 | Form 13G |
| 17 | Lamond David Director |
2025-01-08 19:30:58 | 47,587 0 |
47,587 | Form 4 |
| 18 | Senner Christopher J. Director |
2025-01-08 19:29:14 | 35,274 0 |
35,274 | Form 4 |
| 19 | McLoughlin Margaret Director |
2025-01-08 19:33:26 | 31,613 0 |
31,613 | Form 4 |
| 20 | Bray June Director |
2025-01-08 19:32:09 | 30,282 0 |
30,282 | Form 4 |
| 21 | Monohon Ted Chief Accounting Officer & VP |
2023-03-06 18:55:56 | 27,440 0 |
27,440 | Form 4 |
| 22 | Benatti Luca Director |
2024-06-07 20:57:22 | 27,000 0 |
27,000 | Form 4 |
| 23 | RYAN UNA S Director |
2024-06-07 21:03:00 | 27,000 0 |
27,000 | Form 4 |
| 24 | Sabbagh Marwan Director |
2022-03-16 18:33:46 | 22,058 0 |
22,058 | Form 4 |
| 25 | Patni Rajiv Director |
2024-06-07 20:55:27 | 13,500 0 |
13,500 | Form 4 |
| 26 | YOUNG KEVIN Director |
2020-06-09 20:22:01 | 11,029 0 |
11,029 | Form 4 |
| 27 | EPIQ Capital Group LLC Boeding Chad Former 10% Owner |
2021-02-01 16:25:27 | 0 0 |
0 | Form 5 |